美国家庭检测试剂盒市场 – 行业趋势及 2031 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Healthcare Us At Home Testing Kits Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

美国家庭检测试剂盒市场 – 行业趋势及 2031 年预测

  • Healthcare
  • Upcoming Report
  • Mar 2024
  • Country Level
  • 350 页面
  • 桌子數： 220
  • 图号： 60
立即购买 立即购买

美国家用检测试剂盒市场，按检测类型（妊娠检测、睾酮、性病/性传播感染检测、糖尿病、胆固醇检测、甲状腺检测、传染病、葡萄糖检测、排卵预测检测试剂盒、药物滥用检测试剂盒、癌症检测、其他检测类型）、类型（数字监测仪器、杯子、样品收集套件、盒式磁带、试纸、中游、测试面板、浸卡、其他形式类型）、年龄（儿科、成人、老年人）、样品类型（尿液、血液、唾液、粪便、阴道拭子、精液、其他样品类型）、用途（一次性、可重复使用）、分销渠道（零售药店、药店、医院药店、超市/大卖场、网上药店）划分——行业趋势和预测到 2031 年。

 美国家庭检测试剂盒市场分析及规模

美国家用检测试剂盒市场在医疗保健可及性方面发挥着至关重要的作用，它为各种疾病（包括 COVID-19、性传播感染和慢性病）提供了方便快捷的诊断解决方案。这些试剂盒使人们能够舒适地在家中监测自己的健康状况，从而促进早期发现和干预。市场的增长标志着医疗保健向分散化转变，更加重视主动健康管理，最终有助于改善公共卫生结果并减轻医疗保健系统的负担。

Data Bridge Market Research 分析了美国家用检测试剂盒市场，该市场在 2023 年的规模为 21.8 亿美元，预计到 2031 年将达到 34 亿美元，在 2024 年至 2031 年的预测期内，复合年增长率为 5.70%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

美国家庭检测试剂盒市场范围和细分  

报告指标

细节

预测期

2024-2031

基准年

2023

历史岁月

2022 (可定制为 2016-2021)

定量单位

收入（单位：十亿美元）、销量（单位：台）、定价（美元）

涵盖的领域

测试类型（妊娠测试、睾酮、性病/性传播感染测试、糖尿病、胆固醇测试、甲状腺测试、传染病、葡萄糖测试、排卵预测测试套件、药物滥用测试套件、癌症测试、其他测试类型）、类型（数字监测仪器、杯子、样品收集套件、盒式磁带、试纸、中游、测试面板、浸卡、其他形式类型）、年龄（儿童、成人、老年人）、样品类型（尿液、血液、唾液、粪便、阴道拭子、精液、其他样品类型）、用途（一次性、可重复使用）、分销渠道（零售药店、药店、医院药店、超市/大卖场、网上药店）

涵盖的市场参与者

雅培（美国）、ACON Laboratories, Inc.（美国）、OraSure Technologies, Inc.（美国）、BD（美国）、Cardinal Health（美国）、B. Braun SE（德国）、Siemens Healthcare GmbH（德国）、QuidelOrtho Corporation（美国）、Bionime Corporation（台湾）、SA Scientific Ltd.（美国）、ARKRAY, Inc.（美国）

Everlywell, Inc.（美国）、Sitemap（美国）、Nova Biomedical（美国）、AdvaCare Pharma（美国）、Atlas Medical GmbH（英国）、LifeScan IP Holdings, LLC（美国）、Chembio Diagnostics, Inc.（美国）、TaiDoc Technology Corporation（台湾）、Drägerwerk AG & Co. KGaA（德国）、AccuBioTech Co., Ltd（中国）、F. HoffmannLa Roche Ltd（瑞士）、PRIMA Lab SA（瑞士）、MP BIOMEDICALS（美国）、VedaLab（法国）、Ascensia Diabetes Care Holdings AG（瑞士）

市场机会
  • 技术进步提供精准诊断解决方案
  • 舒适居家的个性化医疗趋势

市场定义

家用检测试剂盒是一种方便且用户友好的诊断工具，旨在让个人在家中舒适地自行进行检测。这些试剂盒通常包括所有必要的组件和样本采集说明，并且可以使用各种测试方法，例如横向流动检测、分子技术或免疫测定。它们通常用于检测特定的健康状况或指标，例如传染病、妊娠激素或遗传倾向。

美国家庭检测试剂盒市场动态

驱动程序

  • 健康意识增强可及早发现

民众对健康和保健意识的不断增强是家庭检测试剂盒市场的重要推动力。家庭检测试剂盒为个人提供了一种方便易行的方式来评估各种健康参数，鼓励预防性医疗保健。随着健康意识的增强，人们越来越重视早期检测和监测，这推动了对各种家庭检测解决方案的需求，从一般健康检查到专门的诊断测试。

  • 方便到达 偏远或服务欠缺的地区

家用检测试剂盒的可获得性对美国市场的增长贡献巨大。随着技术和分销渠道的进步，这些试剂盒已可供广大消费者轻松获得。轻松获得家用检测试剂盒消除了传统医疗环境中存在的障碍，提供了便利和隐私。这种可获得性在偏远或服务不足的地区尤为重要，因为在这些地区，到达医疗机构可​​能具有挑战性。

机会

  • 技术进步提供精准诊断解决方案

技术的不断发展，包括人工智能和物联网 (IoT) 在家用检测试剂盒中的集成，为创新和更准确的诊断解决方案打开了大门。这些进步不仅提高了测试结果的可靠性，还有助于提供用户友好的体验，从而促进更多消费者采用。随着市场拥抱尖端技术，公司有希望脱颖而出并在美国家用检测试剂盒市场占据更大份额。

  • 舒适居家的个性化医疗趋势

随着人们越来越寻求量身定制的健康见解和解决方案，家用检测试剂盒为定制诊断和监测选项提供了机会。在消费者积极寻求个性化和可操作的健康信息、足不出户即可获得的健康环境中，能够开发和销售针对遗传倾向、营养需求或特定健康状况的专用检测试剂盒的公司将蓬勃发展。

限制/挑战

  • 监管挑战导致产品审批延迟

FDA 等机构的严格监管要求可能会导致产品审批和市场准入延迟。遵守复杂的监管框架对公司开发、营销和分销家用检测试剂盒构成了障碍，阻碍了市场的增长潜力。这些挑战增加了将产品推向市场的时间和成本，并增加了行业的不确定性和局限性。

  • 自我测试缺乏准确性  

这一挑战源于自我测试本身的复杂性，与专业测试相比，其结果可能不太准确。由于准确性在诊断过程中至关重要，家用测试套件的可靠性成为一个问题，阻碍了其广泛采用。这一限制可能会影响市场的增长，因为用户寻求确保测试结果的准确性，以便就其健康做出明智的决策。

这份美国家用检测试剂盒市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关美国家用检测试剂盒市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。

最新动态

  • 2022 年 11 月，SalistickTM 推出了基于唾液的妊娠检测试剂盒。SalistickTM 拥有更好的用户体验和高准确度，利用创新技术检测唾液中的妊娠激素 β-hCG，为早期妊娠检测提供了一种新方法
  • 2022 年 6 月，CoviEasy 在印度推出了 Genes2Me Pvt. Ltd. 的 COVID-19 自检快速抗原试剂盒。这款 IVD 产品配有人工智能驱动的移动应用程序，确保易于使用，并在 10 分钟内提供快速结果，准确率超过 98%，为高效、便捷的检测解决方案做出了贡献
  • 2021 年 7 月，雅培在印度推出了 COVID-19 家庭检测试剂盒，方便检测成人和儿童的 SARS-CoV-2 病毒，无论症状如何。此举旨在提高检测的可及性，并为持续的疫情管理做出贡献
  • 2020 年 11 月，ACON Laboratories, Inc. 推出了 Flowflex SARS-COV-2 抗原快速检测试剂。该产品专为诊断疑似活跃 COVID-19 患者而设计，该产品的推出标志着该公司扩大产品范围并增加收入来源的战略举措

美国家庭检测试剂盒市场范围

美国家用检测试剂盒市场根据检测类型、类型、年龄、样本类型、用途和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

测试类型

  • 妊娠试验
  • 睾酮
  • 性病/性传播感染检测
  • 衣原体和淋病
  • HIV 检测
  • 糖尿病
  • 胆固醇检测
  • 甲状腺检测
  • 传染病
  • 葡萄糖测试
  • 排卵预测测试套件
  • 药物滥用检测试剂盒
  • 癌症检测
  • 其他测试类型

类型

  • 数字监测仪器
  • 杯子
  • 样本采集套件
  • 卡式磁带
  • 条
  • 中游
  • 测试面板
  • 浸卡
  • 其他表格类型

年龄

  • 儿科
  • 成人
  • 老年

样品类型

  • 尿
  • 血
  • 唾液
  • 凳子
  • 阴道拭子
  • 精液
  • 其他样品类型

用法

  • 一次性的 
  • 可重复使用的

分销渠道

  • 零售药店
  • 药店
  • 医院药房
  • 超市/大卖场
  • 网上药店

医疗保健基础设施增长安装基础和新技术渗透

美国家庭检测试剂盒市场还为您提供了每个国家/地区资本设备医疗保健支出增长、美国家庭检测试剂盒市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对美国家庭检测试剂盒市场的影响的详细市场分析 。 数据适用于 2016-2021 年的历史时期。

竞争格局和美国家庭检测试剂盒市场份额分析

美国家用检测试剂盒市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、美国业务、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、品牌分析、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对美国家用检测试剂盒市场的关注有关。

美国家庭检测试剂盒市场的一些主要参与者包括：

  • 雅培（美国）
  • ACON Laboratories, Inc.（美国）
  • OraSure Technologies, Inc.（美国）
  • BD（美国）
  • 康德乐 (美国)
  • B. Braun SE（德国）
  • 西门子医疗有限公司（德国）
  • QuidelOrtho Corporation（美国）
  • 生化科技股份有限公司 (台湾)
  • SA Scientific Ltd.（美国）
  • ARKRAY, Inc.（美国）
  • Everlywell, Inc.（美国）
  • 网站地图（美国）
  • Nova Biomedical（美国）
  • AdvaCare Pharma（美国）
  • Atlas Medical GmbH（英国）
  • LifeScan IP Holdings, LLC（美国）
  • Chembio Diagnostics, Inc.（美国）
  • 台科科技股份有限公司 (中国台湾)
  • Drägerwerk AG & Co. KGaA（德国）
  • AccuBioTech 有限公司 (中国)
  • F. HoffmannLa Roche Ltd（瑞士）
  • PRIMA Lab SA（瑞士）
  • MP BIOMEDICALS（美国）
  • VedaLab（法国）
  • Ascensia Diabetes Care Holdings AG（瑞士）

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of U.S. At-Home Testing Kits MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. test type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. secondary sourcEs
    12. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
  5. market overview
    1. drivers
      1. Increasing health consciousness and awareness amongst customers
      2. Growing adoption of self-testing kits
      3. Easy availability of self-testing kit at pharmacies
      4. Ease to use and low costs of rapid self-test kits
      5. Increase in awareness about importance of HIV diagnosis
    2. RESTRAINTS
      1. Inaccuracy of results by self-testing kits
      2. Stringent government regulations for manufacturing and distribution of testing kits
    3. OPPoRTUNITIES
      1. Advent of advanced technologies
      2. Emerging need of rapid testing kits for COVID-19 pandemic
      3. Rise in the adaption of self-testing kits
      4. increase in Strategic decision amongst companies
    4. cHALLENGES
      1. High competition in medical technology industry
      2. reduction in research & development budgets
  6. COVID-19 IMPACT ON U.S. AT-HOME TESTING KITS MARKET
    1. AFTERMATH OF THE NETWORK INDUSTRY AND GOVERNMENT ROLE
    2. STRATEGIC DECISIONS FOR market players AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
    3. IMPACT ON DEMAND & supply chain
    4. CONCLUSION
  7. U.S. at-home testing kits market, BY test type
    1. overview
    2. Glucose Tests
    3. Infectious Diseases
    4. Drug Abuse Test Kits
    5. Pregnancy Test
    6. HIV Test Kit
    7. Ovulation Predictor Test Kit
    8. Others
  8. U.S. at-home testing kits market, BY type
    1. overview
    2. Cassettes
      1. Retail Pharmacies
      2. Online Pharmacies
      3. Drug Store
      4. Supermarket/Hypermarket
    3. Strip
      1. Retail Pharmacies
      2. Online Pharmacies
      3. Drug Store
      4. Supermarket/Hypermarket
    4. Midstream
      1. Retail Pharmacies
      2. Online Pharmacies
      3. Drug Store
      4. Supermarket/Hypermarket
    5. Dip Card
      1. Retail Pharmacies
      2. Online Pharmacies
      3. Drug Store
      4. Supermarket/Hypermarket
    6. Test Panel
      1. Retail Pharmacies
      2. Online Pharmacies
      3. Drug Store
      4. Supermarket/Hypermarket
    7. Others
  9. U.S. at-home testing kits market, BY age
    1. overview
    2. Adult
    3. Geriatric
    4. Pediatric
  10. U.S. at-home testing kits market, BY Sample Type
    1. overview
    2. Urine
    3. Blood
    4. Saliva
    5. Others
  11. U.S. at-home testing kits market, BY Usage
    1. overview
    2. Disposable
    3. Reusable
  12. U.S. at-home testing kits market, BY Distribution Channels
    1. overview
    2. Retail Pharmacies
    3. Online Pharmacies
    4. Drug Store
    5. Supermarket/Hypermarket
  13. U.S. At-Home Testing Kits Market, by REGION
    1. overview
    2. U.S.
      1. U.S.
  14. US At-Home Testing Kits Market company landscape
    1. company share analysis: U.S.
  15. swot analysis
  16. company profile
    1. abbott
      1. COMPANY snapshot
      2. revenue analysis
      3. product PORTFOLIO
      4. recent DEVELOPMENT
    2. Ascensia Diabetes Care Holdings AG
      1. COMPANY snapshot
      2. PRODUCT PORTFOLIO
      3. recent DEVELOPMENT
    3. bd
      1. COMPANY snapshot
      2. REVENUE ANALYSIS
      3. product PORTFOLIO
      4. recent DEVELOPMENTS
    4. F. hoffmann-la roche ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. b. braun melsungen ag
      1. COMPANY snapshot
      2. product PORTFOLIO
      3. recent DEVELOPMENT
    6. Drägerwerk AG & Co. KGaA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. AccuBiotech co., ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. Acon laboratories, inc.
      1. COMPANY snapshot
      2. product PORTFOLIO
      3. recent DEVELOPMENTS
    9. advacare pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. ARKRAY USA, Inc.
      1. COMPANY snapshot
      2. product PORTFOLIO
      3. recent DEVELOPMENTS
    11. atlas medical UK
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. bionime corporation
      1. COMPANY snapshot
      2. REVENUE ANALYSIS
      3. product PORTFOLIO
      4. recent DEVELOPMENT
    13. cardinal health
      1. COMPANY snapshot
      2. REVENUE ANALYSIS
      3. product PORTFOLIO
      4. recent DEVELOPMENT
    14. chembio diagnostics, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    15. Clearblue (A Subsidiary of Clear Blue Technologies Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    16. Eurofins Viracor, Inc. (a subsidiary of EUROFINS SCIENTIFIC)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. Everlywell, inc.
      1. COMPANY snapshot
      2. product PORTFOLIO
      3. recent DEVELOPMENTS
    18. lifescan ip holdings, llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    19. MP BIOMEDICALS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    20. MYLAN N.V. (A SUBSIDIARY OF VIATRIS INC.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    21. NOVa biomedical
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    22. Orasure technologies, inc.
      1. COMPANY snapshot
      2. REVENUE ANALYSIS
      3. product PORTFOLIO
      4. recent DEVELOPMENTS
    23. Piramal enterprises ltd.
      1. COMPANY snapshot
      2. REVENUE ANALYSIS
      3. product PORTFOLIO
      4. recent DEVELOPMENTS
    24. prima lab sa
      1. COMPANY snapshot
      2. product PORTFOLIO
      3. recent DEVELOPMENT
    25. quidel corporation
      1. COMPANY snapshot
      2. REVENUE ANALYSIS
      3. product PORTFOLIO
      4. recent DEVELOPMENTS
    26. rapikit
      1. COMPANY snapshot
      2. revenue analysis
      3. product PORTFOLIo
      4. recent DEVELOPMENT
    27. RUNBIO BIOTECH CO.,LTD.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    28. SA scientific
      1. COMPANY snapshot
      2. product PORTFOLIO
      3. recent DEVELOPMENT
    29. Sensing self, pte. ltd
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    30. siemens healthcare gmbh
      1. COMPANY snapshot
      2. REVENUE ANALYSIS
      3. product PORTFOLIO
      4. recent DEVELOPMENT
    31. taidoc technology corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    32. vedalab
      1. COMPANY snapshot
      2. PRODUCT PORTFOLIO
      3. recent DEVELOPMENT
  17. questionnaire
  18. related reports

表格列表

TABLE 1 U.S. At-Home Testing Kits Market, By Type, 2019-2028 (USD Million)

TABLE 2 U.S. Cassettes in At-Home Testing Kits Market, By Distribution Channels, 2019-2028 (USD Million)

TABLE 3 U.S. Strip in At-Home Testing Kits Market, By Distribution Channels, 2019-2028 (USD Million)

TABLE 4 U.S. Midstream in At-Home Testing Kits Market, By Distribution Channels, 2019-2028 (USD Million)

TABLE 5 U.S. Dip Card in At-Home Testing Kits Market, By Distribution Channels, 2019-2028 (USD Million)

TABLE 6 U.S. Test Panel in At-Home Testing Kits Market, By Distribution Channels, 2019-2028 (USD Million)

TABLE 7 U.S. At-Home Testing Kits Market, By age, 2019-2028 (USD Million)

TABLE 8 U.S. At-Home Testing Kits Market, By Sample Type, 2019-2028 (USD Million)

TABLE 9 U.S. At-Home Testing Kits Market, By Usage, 2019-2028 (USD Million)

TABLE 10 U.S. At-Home Testing Kits Market, By test Type, 2019-2028 (USD Million)

TABLE 11 U.S. At-Home Testing Kits Market, By Type, 2019-2028 (USD Million)

TABLE 12 U.S. Cassettes in At-Home Testing Kits Market, By Distribution Channels, 2019-2028 (USD Million)

TABLE 13 U.S. Strip in At-Home Testing Kits Market, By Distribution Channels, 2019-2028 (USD Million)

TABLE 14 U.S. Midstream in At-Home Testing Kits Market, By Distribution Channels, 2019-2028 (USD Million)

TABLE 15 U.S. Dip Card in At-Home Testing Kits Market, By Distribution Channels, 2019-2028 (USD Million)

TABLE 16 U.S. Test Panel in At-Home Testing Kits Market, By Distribution Channels, 2019-2028 (USD Million)

TABLE 17 U.S. At-Home Testing Kits Market, By Age, 2019-2028 (USD Million)

TABLE 18 U.S. At-Home Testing Kits Market, By Sample Type, 2019-2028 (USD Million)

TABLE 19 U.S. At-Home Testing Kits Market, By Usage, 2019-2028 (USD Million)

TABLE 20 U.S. At-Home Testing Kits Market, By Distribution Channels, 2019-2028 (USD Million)

图片列表

FIGURE 1 U.S. At-Home Testing Kits market: segmentation

FIGURE 2 U.S. At-Home Testing Kits MARKET: data triangulation

FIGURE 3 U.S. At-Home Testing Kits market: DROC ANALYSIS

FIGURE 4 U.S. At-Home Testing Kits market: U.S. vs regional MARKET ANALYSIS

FIGURE 5 U.S. At-Home Testing Kits MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 U.S. At-Home Testing Kits MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 U.S. At-Home Testing Kits market: DBMR MARKET POSITION GRID

FIGURE 8 U.S. At-Home Testing Kits market: VENDOR SHARE ANALYSIS

FIGURE 9 U.S. At-Home Testing Kits market: SEGMENTATION

FIGURE 10 Growing Adoption of self-testing kits is expected to DRIVe U.S. At-Home Testing Kits MARKET IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 11 glucose tests segment is expected to account for the largest share of U.S. At-Home Testing Kits market in 2021 & 2028

FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF U.S. AT-HOME TESTING KITS MARKET

FIGURE 13 U.S. at-home testing kits MARKET: BY test type, 2020

FIGURE 14 U.S. at-home testing kits MARKET: BY type, 2020

FIGURE 15 U.S. at-home testing kits MARKET: BY age, 2020

FIGURE 16 U.S. at-home testing kits MARKET: BY Sample Type, 2020

FIGURE 17 U.S. at-home testing kits MARKET: BY Usage, 2020

FIGURE 18 U.S. at-home testing kits MARKET: BY Distribution Channels, 2020

FIGURE 19 U.S. At-Home Testing Kits MARKET: by Country (2020 & 2028)

FIGURE 20 U.S. At-Home Testing Kits MARKET: by test Type (2021-2028)

FIGURE 21 U.S. at-home testing kits Market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The U.S. At-Home Testing Kits Market size will be worth USD 3.40 billion by 2031 during the forecast period.
The U.S. At-Home Testing Kits Market growth rate is 5.70% during the forecast period.
The Rising Health Awareness Leads to Early Detection and Easy Accessibility in Distant or Underserved Regions are the growth drivers of the U.S. At-Home Testing Kits Market.
The test type, type, age, sample type, usage, and distribution channels are the factors on which the U.S. At-Home Testing Kits Market research is based.
The major companies in the U.S. At-Home Testing Kits Market are Abbott (U.S.), ACON Laboratories, Inc. (U.S.), OraSure Technologies, Inc. (U.S.), BD (U.S.), Cardinal Health (U.S.), B. Braun SE (Germany), Siemens Healthcare GmbH (Germany), QuidelOrtho Corporation (U.S.), Bionime Corporation (Taiwan), SA Scientific Ltd. (U.S.), ARKRAY, Inc. (U.S.) Everlywell, Inc. (U.S.), Sitemap (U.S.), Nova Biomedical (U.S.), AdvaCare Pharma (U.S.), Atlas Medical GmbH(U.K.), LifeScan IP Holdings, LLC (U.S.), Chembio Diagnostics, Inc. (U.S.), TaiDoc Technology Corporation (Taiwan), Drägerwerk AG & Co. KGaA (Germany), AccuBioTech Co., Ltd (China), F. HoffmannLa Roche Ltd (Switzerland), PRIMA Lab SA (Switzerland), MP BIOMEDICALS (U.S.), VedaLab (France), Ascensia Diabetes Care Holdings AG (Switzerland).

浏览相关页面

Banner